Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024
Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Open Forum Infectious Diseases
|
January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Mark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M Lewis, Eric A Naioti, Wesley H Self, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 16, 2022
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
BMJ (Clinical Research Ed.)
|
March 10, 2022
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 24, 2022
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022
Mark W Tenforde, Wesley H Self, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 6, 2021
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024
Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024
Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Open Forum Infectious Diseases
|
January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Mark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
Nathaniel M Lewis, Eric A Naioti, Wesley H Self, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 16, 2022
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
BMJ (Clinical Research Ed.)
|
March 10, 2022
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S Lauring, Mark W Tenforde, James D Chappell, et al.
MMWR. Morbidity and Mortality Weekly Report
|
March 24, 2022
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022
Mark W Tenforde, Wesley H Self, Manjusha Gaglani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 6, 2021
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States
Mark W Tenforde, Manish M Patel, Adit A Ginde, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024
Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Page
of 8